Nature Medicine, volume 25, issue 6, pages 977-987

IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure

Lenette L. Lu 1, 2
Malisa T. Smith 3
Krystle K Q Yu 3
Corinne Luedemann 2
Todd J Suscovich 2
Patricia S. Grace 2
Adam Cain 2
Wen-Han Yu 2, 4
Tanya R Mckitrick 5
Douglas Lauffenburger 4
Richard D Cummings 5
Harriet Mayanja-Kizza 6
Thomas R. Hawn 3
W. Henry Boom 7
Catherine M. Stein 7, 8
Sarah A Fortune 1, 2
Chetan Seshadri 3
Galit Alter 2
Show full list: 18 authors
Publication typeJournal Article
Publication date2019-05-20
Journal: Nature Medicine
scimago Q1
SJR19.045
CiteScore100.9
Impact factor58.7
ISSN10788956, 1546170X, 17447933
General Biochemistry, Genetics and Molecular Biology
General Medicine
Abstract
Exposure to Mycobacterium tuberculosis (Mtb) results in heterogeneous clinical outcomes including primary progressive tuberculosis and latent Mtb infection (LTBI). Mtb infection is identified using the tuberculin skin test and interferon-γ (IFN-γ) release assay IGRA, and a positive result may prompt chemoprophylaxis to prevent progression to tuberculosis. In the present study, we report on a cohort of Ugandan individuals who were household contacts of patients with TB. These individuals were highly exposed to Mtb but tested negative by IFN-γ release assay and tuberculin skin test, ‘resisting’ development of classic LTBI. We show that ‘resisters’ possess IgM, class-switched IgG antibody responses and non-IFN-γ T cell responses to the Mtb-specific proteins ESAT6 and CFP10, immunologic evidence of exposure to Mtb. Compared to subjects with classic LTBI, ‘resisters’ display enhanced antibody avidity and distinct Mtb-specific IgG Fc profiles. These data reveal a distinctive adaptive immune profile among Mtb-exposed subjects, supporting an expanded definition of the host response to Mtb exposure, with implications for public health and the design of clinical trials. New immune biomarkers of exposure to tuberculosis may require a rethink of evidence of Mycobacterium tuberculosis infection and control.
Found 
Found 

Top-30

Journals

5
10
15
20
25
5
10
15
20
25

Publishers

5
10
15
20
25
30
35
40
5
10
15
20
25
30
35
40
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST | RIS | BibTex | MLA
Found error?